Success Metrics

Clinical Success Rate
86.7%

Based on 26 completed trials

Completion Rate
87%(26/30)
Active Trials
35(27%)
Results Posted
15%(4 trials)
Terminated
4(3%)

Phase Distribution

Ph early_phase_1
1
1%
Ph phase_1
4
3%
Ph phase_3
19
15%
Ph phase_2
16
13%
Ph not_applicable
77
60%
Ph phase_4
7
5%

Phase Distribution

5

Early Stage

16

Mid Stage

26

Late Stage

Phase Distribution124 total trials
Early Phase 1First-in-human
1(0.8%)
Phase 1Safety & dosage
4(3.2%)
Phase 2Efficacy & side effects
16(12.9%)
Phase 3Large-scale testing
19(15.3%)
Phase 4Post-market surveillance
7(5.6%)
N/ANon-phased studies
77(62.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.3%

26 of 32 finished

Non-Completion Rate

18.8%

6 ended early

Currently Active

35

trials recruiting

Total Trials

128

all time

Status Distribution
Active(68)
Completed(26)
Terminated(6)
Other(28)

Detailed Status

Recruiting34
Not yet recruiting31
Completed26
unknown26
Terminated4
Suspended2

Development Timeline

Analytics

Development Status

Total Trials
128
Active
35
Success Rate
86.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.8%)
Phase 14 (3.2%)
Phase 216 (12.9%)
Phase 319 (15.3%)
Phase 47 (5.6%)
N/A77 (62.1%)

Trials by Status

suspended22%
completed2620%
not_yet_recruiting3124%
unknown2620%
withdrawn22%
active_not_recruiting11%
terminated43%
recruiting3427%
enrolling_by_invitation22%

Recent Activity

Clinical Trials (128)

Showing 20 of 128 trialsScroll for more
NCT07855679

Pulmonary Embolism Registry From Emergency to Long-Term Follow-Up and Surveillance

Recruiting
NCT07475949Phase 3

Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging

Recruiting
NCT07642076Phase 4

Evaluation of the Clinical Impact of Adjunctive L-carnitine Therapy in Critically Ill Hepatic Patients Admitted to Intensive Care Unit

Recruiting
NCT07835516Not Applicable

Electroconvulsive Therapy for Refractory Fibromyalgia

Not Yet Recruiting
NCT07260916Not Applicable

Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation

Recruiting
NCT05895136Phase 2

A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).

Recruiting
NCT07763145Not Applicable

Effect of Citicoline on Neurological Severity Score and Cerebral Doppler Resistive Index in Neonatal Hypoxic Ischemic Encephalopathy

Not Yet Recruiting
NCT07137832Phase 3

OPtimizing REperfusion by Primary Intra-Arterial ThRomboLysis for Medium Vessel Occlusion

Recruiting
NCT07281027Phase 3

COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

Not Yet Recruiting
NCT06819852Not Applicable

Acute Hospital Care at Home for People Living With Dementia

Not Yet Recruiting
NCT07275697Phase 4

Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study

Recruiting
NCT07506499Not Applicable

Cardiac Rehabilitation in Decompensated Heart Failure

Recruiting
NCT07737886Not Applicable

Feasibility, Acceptability, and Preliminary Effects of Virtual Reality for Pain, Anxiety and Recovery Enhancement of Children Post-scoliosis Surgical Repair

Not Yet Recruiting
NCT07573163Phase 2

Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion

Recruiting
NCT07719504Not Applicable

Implementation of Physical Therapy Protocol for Functional Constipation

Not Yet Recruiting
NCT07168993Not Applicable

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

Recruiting
NCT07701512Phase 2

Clinical Study to Evaluate the Efficacy of Febuxostat in the Treatment of Conservatively Managed Intracranial Hemorrhage Patients

Recruiting
NCT04948749Not Applicable

Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial

Recruiting
NCT07692256Phase 2

the Clinical Outcome of Empagliflozin in Pediatric Heart Failure Patients

Recruiting
NCT07505199Phase 1

Safety and Efficacy of FAP iCDC in Ischemic Cardiomyopathy

Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
128